Entrepreneur Programme gets $110m revamp
9 April 2020 James Riley, Editorial Director – InnovationAus. In a massive revamp of its flagship Entrepreneurs Programme, the Industry department has awarded four tender contracts worth a combined $110 million for delivering the program’s commercial outcomes. The contracts…
Building capacity in clinical research during the COVID-19 Pandemic in Australia
9 April 2020 ARCS Australia is coordinating a call for qualified volunteers who are willing to be called upon/volunteer in case of potential staff shortages to assist with the support of current clinical trials and any new COVID-19…
Seeking knowledge and expertise to tackle COVID-19
9 April 2020 A new database designed to make it easier for Australian experts to contribute to tackling COVID-19 has been launched, championed by Australia’s Chief Scientist, Dr Alan Finkel. An initiative of the Learned Academies of Australia,…
AMGC COVID-19 Manufacturer Response Register
9 April 2020 The Advanced Manufacturing Growth Centre have created a register seeking expressions of interest from Australian manufacturers and others looking to assist with supply of goods, services or knowledge during the current COVID-19 outbreak. Visit the…
Doherty Institute release COVID-19 modelling papers
7 April 2020 Doherty Institute researchers have released their work on COVID-19 modelling to the general public. These models have been utilised by the Commonwealth Government in the public health response to COVID-19. It’s important to note the modelling is…
Call for Australian manufacturers to supply COVID-19 test kit components
6 April 2020 Are you an Australian manufacturer with the capability to produce inputs for COVID-19 RNA extraction? Do you have support to scale up your production? We want to hear from you. Securing Australia’s COVID-19 testing capacity…
Possible coronavirus drug identified by Monash University scientists
3 April 2020 A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint venture of the University of Melbourne and Royal Melbourne Hospital, has shown that…
Where are we at with developing a vaccine for coronavirus?
3 April 2020 This article is republished from The Conversation under a Creative Commons license. Read the original article. Shutterstock Kylie Quinn, RMIT University and Damian Purcell, The Peter Doherty Institute for Infection and Immunity SARS-CoV-2, the virus…
CSIRO begins testing COVID-19 vaccines
2 April 2020 CSIRO, Australia’s national science agency, has commenced the first stage of testing potential vaccines for COVID-19. The testing, expected to take three months, is underway at CSIRO’s high-containment biosecurity facility, the Australian Animal Health Laboratory…
Impact of COVID-19 on Product Development: Information and Resource from Halloran
2 April 2020 Read the full statement from Halloran here. Halloran has formed a company-wide task force to curate information on the impact to the life science industry due to the current COVID-19 environment. We are leveraging our…
The Pratt Foundation commits $1 million to support clinical trials for COVID-19 treatments
31 March 2020 The Doherty Institute has welcomed a generous commitment of $1 million from Anthony Pratt and The Pratt Foundation, which will be directed towards the Australasian COVID-19 Trial (ASCOT). Led by the Royal Melbourne Hospital’s infectious…
COVID-19: Guidance on clinical trials for institutions, HRECs, researchers and sponsors
31 March 2020 COVID-19: Guidance on clinical trials for institutions, HRECs, researchers and sponsors is a joint statement that reflects the shared views of all state and territory Departments of Health, the Therapeutic Goods Administration (TGA), National Health…
